A critical advance in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in many forms of cancer, leading https://prbookmarkingwebsites.com/story29912412/vhh-fragments-restore-tumor-suppressor-p53-a-new-approach-for-malignant-treatment